SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 13th, 2022 • Kintara Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 12, 2022, between Kintara Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT KINTARA THERAPEUTICS, INC.Common Stock Purchase • April 13th, 2022 • Kintara Therapeutics, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 14, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 14, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kintara Therapeutics, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT kintara therapeutics, inc.Kintara Therapeutics, Inc. • April 13th, 2022 • Pharmaceutical preparations
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 14, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 14, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kintara Therapeutics, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Placement Agent Agreement, dated as of April 12, 2022 by and between the Company and A.G.P./Alliance Global Partners.
Kintara Therapeutics, Inc.Kintara Therapeutics, Inc. • April 13th, 2022 • Pharmaceutical preparations • New York
